Domov › Rak ledvic (renocelularni karcinom) › Oregon › Portland

Klinične študije za Rak ledvic (renocelularni karcinom) v Portland, OR

11 študij za Rak ledvic (renocelularni karcinom) išče udeležence na lokacijah v Portland in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland
Providence Willamette Falls Medical Center, Oregon City · 12 mi stran

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Vključevanje udeležencevFaza 1

Exelixis Clinical Site #51, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Vključevanje udeležencevFaza 2

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland
Oregon Health and Science University, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Vključevanje udeležencevFaza 1/2

Northwest Cancer Specialists, P.C., Portland

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07227415

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Vključevanje udeležencevFaza 3

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland
Oregon Health and Science University, Portland
in še 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06661720

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

Providence Cancer Center Oncology and Hematology Care- Eastside, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Providence Cancer Institute, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06242470

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Vključevanje udeležencevFaza 1/2

Oregon Health & Science University (3485 S. Bond), Portland

Starost 18 in več · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT03972657

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Vključevanje udeležencevFaza 4

OHSU Knight Cancer Institute, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT07405086

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Vključevanje udeležencevFaza 1

Oregon Health & Science University, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Vključevanje udeležencevFaza 3

Kaiser Permanente Northwest, Portland
Oregon Health and Science University, Portland

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2025 · NCT04510597

Študije za Rak ledvic (renocelularni karcinom) v drugih mestih

Druge študije v Portland

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.